Professor John Marshall
...and will test two different types of drugs that he has been developing to stop αvβ6 working, and determine when and how best they could potentially be used for patients....
Professor Laura Machesky
...has also identified a number of chemical compounds that affect fascin1 and will join forces with drug discovery colleagues to test how these affect the migration, invasion and spread of...
Dr Laura Woods
...linked routine data: full case-control study and economic evaluation Project Aims: Refine previous modelling tool using more patients and up-to-date information; assess real-life use and potential cost to the NHS....
About the pancreas
...and tapers into a tail at the other end. Pancreatic cancer usually arises in the head of the pancreas (80%) and less commonly in the body (15%) and tail (5%)....
Dr Tatjana Crnogorac-Jurcevic
...still remains completely unknown. The aim of this study is to decipher its role in the pathobiology of pancreatic cancer and assess its validity as a diagnostic and/or prognostic tool....
Why I support the UroPanc study: Will
...cancer and exactly 5 weeks from that day to her death, aged 50. A petite, fit and active, non- smoking vegetarian whom everyone adored. Christmas 2014: our sons Jack and...
Why I support the UroPanc study: Karen
...I don’t want it to find anything. The wait for the results is an anxious one and the relief on hearing the ‘all clear’ is huge, especially as I approach...
Test
Dr Claire Wells
Project Title: Validation of the PAK4:PI3K nexus as a therapeutic target in pancreatic cancer Project Aims: Dr Wells will investigate the interaction between two proteins called PAK4 and p85, which...
Dr Stephanie Kermorgant
...recently discovered evidence which shed new light on how c-Met functions, and they will use this information to test out different drug compounds which could prevent the molecule from working...